We also analyzed the prevalence of loss of heterozygosity in cutaneous melanoma and observed that patients with ARID1A mutation had higher prevalence compared to those with ARID2 mutation (15.38% vs 4.46%, q = 0.044)—Fig. 2b. Here, ARID1A is linked to cutaneous melanoma.